Insights from Preclinical Choice Models on Treating Drug Addiction

Overview

Journal Trends Pharmacol Sci

Specialty Pharmacology

Date 2016 Dec 6

PMID 27916279

Citations 89

Authors

Matthew L Banks

S Stevens Negus

Affiliations

Soon will be listed here.

Abstract

Substance-use disorders are a global public health problem that arises from behavioral misallocation between drug use and more adaptive behaviors maintained by nondrug alternatives (e.g., food or money). Preclinical drug self-administration procedures that incorporate a concurrently available nondrug reinforcer (e.g., food) provide translationally relevant and distinct dependent measures of behavioral allocation (i.e., to assess the relative reinforcing efficacy of the drug) and behavioral rate (i.e., to assess motor competence). In particular, preclinical drug versus food 'choice' procedures have produced increasingly concordant results with both human laboratory drug self-administration studies and double-blind placebo-controlled clinical trials. Accordingly, here we provide a heuristic framework of substance-use disorders based on a behavioral-centric perspective and recent insights from these preclinical choice procedures.

Citing Articles

Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment.

Allen M, Rahimi O, Johnson B, Cao J, Newman A, Nader M J Pharmacol Exp Ther. 2025; 392(1):100033.

PMID: 39892998 PMC: 11822870. DOI: 10.1124/jpet.124.002356.

Effects of the kappa-opioid receptor antagonist nor-binaltorphimine on methamphetamine-vs-food choice in male rhesus monkeys.

Banks M, Rice K Drug Alcohol Depend. 2024; 266:112518.

PMID: 39612720 PMC: 11685031. DOI: 10.1016/j.drugalcdep.2024.112518.

The function of the ZFP189 transcription factor in the nucleus accumbens facilitates cocaine-specific transcriptional and behavioral adaptations.

Picone J, Hassan A, Kim R, Lira D, Silva G, Truby N Mol Psychiatry. 2024; .

PMID: 39587295 DOI: 10.1038/s41380-024-02852-7.

Validation of drug-nondrug choice procedure to model maladaptive behavioural allocation to opioid use in rats.

Azizzadeh S, Rahimpour M, Rakhshan K, Makkiabadi B, Riahi E Addict Biol. 2024; 29(10):e13442.

PMID: 39380306 PMC: 11461753. DOI: 10.1111/adb.13442.

Choice of alcohol over a natural reward: an experimental study in light and heavy social drinkers.

Karlsson H, Mcntyre S, Gustavson S, Andersson D, Szczot I, Heilig M Psychopharmacology (Berl). 2024; 242(2):327-336.

PMID: 39358610 PMC: 11775076. DOI: 10.1007/s00213-024-06679-6.

References

Maguire D, Gerak L, France C . Delay discounting of food and remifentanil in rhesus monkeys. Psychopharmacology (Berl). 2013; 229(2):323-30. PMC: 3758423. DOI: 10.1007/s00213-013-3121-x. View

Lamb R, Maguire D, Ginsburg B, Pinkston J, France C . Determinants of choice, and vulnerability and recovery in addiction. Behav Processes. 2016; 127:35-42. PMC: 4968700. DOI: 10.1016/j.beproc.2016.04.001. View

Greenwald M, Lundahl L, Steinmiller C . Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. Neuropsychopharmacology. 2010; 35(13):2624-37. PMC: 2978797. DOI: 10.1038/npp.2010.175. View

Perry A, Westenbroek C, Jagannathan L, Becker J . The Roles of Dopamine and α1-Adrenergic Receptors in Cocaine Preferences in Female and Male Rats. Neuropsychopharmacology. 2015; 40(12):2696-704. PMC: 4864645. DOI: 10.1038/npp.2015.116. View

Hutsell B, Cheng K, Rice K, Negus S, Banks M . Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol. 2015; 21(2):360-73. PMC: 4496334. DOI: 10.1111/adb.12206. View

Lenoir M, Cantin L, Vanhille N, Serre F, Ahmed S . Extended heroin access increases heroin choices over a potent nondrug alternative. Neuropsychopharmacology. 2013; 38(7):1209-20. PMC: 3656363. DOI: 10.1038/npp.2013.17. View

Becker J, Koob G . Sex Differences in Animal Models: Focus on Addiction. Pharmacol Rev. 2016; 68(2):242-63. PMC: 4813426. DOI: 10.1124/pr.115.011163. View

Findley J, ROBINSON W, Peregrino L . Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychopharmacologia. 1972; 26(2):93-114. DOI: 10.1007/BF00422097. View

Payer D, Behzadi A, Kish S, Houle S, Wilson A, Rusjan P . Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology. 2013; 39(2):311-8. PMC: 3870773. DOI: 10.1038/npp.2013.192. View

10.

Perez-Mana C, Castells X, Vidal X, Casas M, Capella D . Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials. J Subst Abuse Treat. 2010; 40(2):109-22. DOI: 10.1016/j.jsat.2010.08.012. View

11.

Catania A . Concurrent performances: a baseline for the study of reinforcement magnitude. J Exp Anal Behav. 1963; 6:299-300. PMC: 1404290. DOI: 10.1901/jeab.1963.6-299. View

12.

Bennett J, Stoops W, Rush C . Alternative reinforcer response cost impacts methamphetamine choice in humans. Pharmacol Biochem Behav. 2012; 103(3):481-6. PMC: 3545088. DOI: 10.1016/j.pbb.2012.09.025. View

13.

Nader M, Woolverton W . Effects of increasing response requirement on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl). 1992; 108(3):295-300. DOI: 10.1007/BF02245115. View

14.

Negus S . Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl). 2004; 176(2):204-13. DOI: 10.1007/s00213-004-1878-7. View

15.

Banks M, Blough B, Negus S . Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys. Neuropsychopharmacology. 2012; 38(3):395-404. PMC: 3547190. DOI: 10.1038/npp.2012.193. View

16.

Haney M, Spealman R . Controversies in translational research: drug self-administration. Psychopharmacology (Berl). 2008; 199(3):403-19. PMC: 2731701. DOI: 10.1007/s00213-008-1079-x. View

17.

Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks V . Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet. 2016; 387(10034):2226-34. DOI: 10.1016/S0140-6736(16)00205-1. View

18.

Negus S, Rice K . Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Neuropsychopharmacology. 2008; 34(4):899-911. PMC: 2639629. DOI: 10.1038/npp.2008.127. View

19.

Stafford D, Rice K, Lewis D, Glowa J . Response requirements and unit dose modify the effects of GBR 12909 on cocaine-maintained behavior. Exp Clin Psychopharmacol. 2000; 8(4):539-48. DOI: 10.1037//1064-1297.8.4.539. View

20.

Czoty P, Stoops W, Rush C . Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev. 2016; 68(3):533-62. PMC: 4931869. DOI: 10.1124/pr.115.011668. View